2025: Elimination of Hepatitis C in Taiwan 5 years earlier
Later City News: Taiwan is on track to accelerating Hepatitis C elimination by 2025.
Taiwan accelerated its efforts to eliminate hepatitis C in 2018 by committing to achieve WHO's 2030 goal of treating 80% of eligible patients by 2025. It is doing this by treating 250 000 chronic hepatitis C (CHC) patients with direct-acting antivirals (DAAs) under Hepatitis C Policy Guideline 2018-2025 that increases policy effectiveness, communication, and coordination.
With the goal of reaching 80% treatment coverage, the Taiwan Hepatitis C Policy Guideline's triple focus – therapy spearheads prevention, screening supports therapy and prevention secures out-come4 – will help Taiwan achieve WHO's HCV elimination goal by 2025.
The authors of this paper Grace Hui‐Min Wu, Raoh‐Fang Pwu, Shih‐Chung Chen, Ding‐Shinn Chen hope other countries can benefit from our experience.